Sourcing Lanifibranor?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
pharmaceutical raw material
Sourcing Lanifibranor?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Lanifibranor is a chemical compound that acts as a pan-peroxisome proliferator-activated receptor (PPAR) agonist, targeting PPAR-alpha, PPAR-beta, and PPAR-gamma simultaneously. It is being investigated in clinical trials for nonalcoholic steatohepatitis (NASH) and has shown potential to improve both steatohepatitis and fibrosis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
The international HS code for Lanifibranor (CAS 927961-18-0) is 2935.90.
2935.90
2935 90 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloroindol-2-yl]butanoic acid
OQDQIFQRNZIEEJ-UHFFFAOYSA-N
C1=CC2=C(C=C1S(=O)(=O)N3C4=C(C=C(C=C4)Cl)C=C3CCCC(=O)O)SC=N2